Antibiotic, Antiviral & Genito Urinary Medicines
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- 23.5 month (est.)
- Value
- £36M
- Sector
- HEALTH
- Published
- 20 Apr 2022
- Delivery
- To 09 Apr 2024 (est.)
- Deadline
- n/a
Concepts
Location
Edinburgh
Geochart for 2 buyers and 54 suppliers
2 buyers
- NHS National Services Scotland NSS Edinburgh
37 suppliers
- Accord Healthcare North Harrow
- Aventis Pharma Reading
- B Braun Medical Sheffield
- Bayer Reading
- CST Pharma Walsall
- Fresenius Kabi Runcorn
- Glaxosmithkline Brentford
- Glenmark Pharmaceuticals Europe Watford
- Martindale Pharma Romford
- Merck Sharp & Dohme Hoddesdon
- Tillomed Laboratories Luton
- Aspire Pharma Petersfield
- Bowmed Ibisqus Wrexham
- Ranbaxy London
- Selective Supplies Haywards Heath
- Brown & Burk West London
- Consilient Health Richmond
- Crescent Pharma Basingstoke
- DR Reddys Laboratories Beverley
- Flynn Pharma Stevenage
- Hameln Pharma Gloucester
- Kent Pharmaceuticals Ashford
- Mercury Pharma Group Croydon
- Milpharm South Ruislip
- Morningside Pharmaceuticals Leicestershire
- Mylan UK Healthcare Potters Bar
- Neon Healthcare Ware
- Sandoz Camberley
- Rosemont Pharmaceuticals Leeds
- Teva Castleford
- Thornton & Ross Huddersfield
- Torrent Pharma Crawley
- Wockhardt Wrexham
- Pfizer Tadworth
- Zentiva Pharma London
- Pari Medical West Byfleet
- Chiesi Manchester
Description
This Framework Agreement is for the supply of Antibiotic, Antiviral & Genito Urinary Medicines to health boards across NHS Scotland. The Goods have been split into four (4) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Lot Division
| 1 | Antibiotic, Antiviral & Genito Urinary Medicines Supply of Antibiotic, Antiviral & Genito Urinary Medicines to NHS Scotland. The Authority has awarded each product line within this Lot to a single Framework Participant. Award Criteria
| ||||||||
| 2 | Tobramycin, Colistimethate and Dornase Alfa Medicines for Inhalation Supply of Tobramycin, Colistimethate and Dornase Alfa Medicines for Inhalation to NHS Scotland in a range of presentations. The Authority has awarded each product line as an unranked multi-supplier framework agreement on a line by line basis to a maximum of five (5) Framework Participants. Award Criteria
| ||||||||
| 3 | Emergency Planning Antibiotics The Emergency Planning Antibiotic Lot includes six (6) products to be directly purchased by the Authority with direct deliveries to one nominated distributor to be held locally in Scotland for Emergency Pandemic purposes. The Authority has awarded each product line within this Lot to a single Framework Participant. Award Criteria
| ||||||||
| 4 | Antibiotics for supply to the National NHS Pharmaceutical Specials Service (PSS) This Lot is for the supply of twenty five (25) Antibiotic products direct to the National NHS Pharmaceutical Specials Service (PSS), based in NHS Tayside. The Authority has awarded twelve (12) product lines within this lot, each product line awarded to a single Framework Participant. Award Criteria
|
Award Detail
| 1 | Accord Healthcare (North Harrow)
|
| 2 | Aventis Pharma (Reading)
|
| 3 | B Braun Medical (Sheffield)
|
| 4 | Bayer (Reading)
|
| 5 | CST Pharma (Walsall)
|
| 6 | Fresenius Kabi (Runcorn)
|
| 7 | Glaxosmithkline (Brentford)
|
| 8 | Glenmark Pharmaceuticals Europe (Watford)
|
| 9 | Martindale Pharma (Romford)
|
| 10 | Merck Sharp & Dohme (Hoddesdon)
|
| 11 | Tillomed Laboratories (Luton)
|
| 12 | Aspire Pharma (Petersfield)
|
| 13 | Bowmed Ibisqus (Wrexham)
|
| 14 | Ranbaxy (London)
|
| 15 | Selective Supplies (Haywards Heath)
|
| 16 | Brown & Burk (West London)
|
| 17 | Consilient Health (Richmond)
|
| 18 | Crescent Pharma (Basingstoke)
|
| 19 | DR Reddys Laboratories (Beverley)
|
| 20 | Flynn Pharma (Stevenage)
|
| 21 | Hameln Pharma (Gloucester)
|
| 22 | Kent Pharmaceuticals (Ashford)
|
| 23 | Mercury Pharma Group (Croydon)
|
| 24 | Milpharm (South Ruislip)
|
| 25 | Morningside Pharmaceuticals (Leicestershire)
|
| 26 | Mylan UK Healthcare (Potters Bar)
|
| 27 | Neon Healthcare (Ware)
|
| 28 | Sandoz (Camberley)
|
| 29 | Rosemont Pharmaceuticals (Leeds)
|
| 30 | Teva (Castleford)
|
| 31 | Thornton & Ross (Huddersfield)
|
| 32 | Torrent Pharma (Crawley)
|
| 33 | Wockhardt (Wrexham)
|
| 34 | Pfizer (Tadworth)
|
| 35 | Zentiva Pharma (London)
|
| 36 | Martindale Pharma (Romford)
|
| 37 | Pfizer (Tadworth)
|
| 38 | Pari Medical (West Byfleet)
|
| 39 | Ranbaxy (London)
|
| 40 | Chiesi (Manchester)
|
| 41 | Flynn Pharma (Stevenage)
|
| 42 | Kent Pharmaceuticals (Ashford)
|
| 43 | Mylan UK Healthcare (Potters Bar)
|
| 44 | Teva (Castleford)
|
| 45 | Zentiva Pharma (London)
|
| 46 | Bowmed Ibisqus (Wrexham)
|
| 47 | Sandoz (Camberley)
|
| 48 | Wockhardt (Wrexham)
|
| 49 | Brown & Burk (West London)
|
| 50 | Kent Pharmaceuticals (Ashford)
|
| 51 | Mylan UK Healthcare (Potters Bar)
|
| 52 | Sandoz (Camberley)
|
| 53 | Ranbaxy (London)
|
| 54 | Selective Supplies (Haywards Heath)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price.
Other Information
The estimated value(s) referred to in Section II.1.5 & All Lots cover(s) the twenty four (24) month contract duration and the twenty-four (24) month extension period of the framework agreement. Full details are available on request from the Authority for all awarded products within each Lot. (SC Ref:688061)
Reference
- FTS 010266-2022